Today, healthcare innovation centers on advancing breakthrough treatments to improve patient outcomes. Focused Ultrasound is a revolutionary, noninvasive therapy that can treat multiple diseases and has the potential to address many more with further R&D funding. Join us to learn how, for many patients, this noninvasive, non-pharmacological treatment is a significant improvement over conventional therapies and reduces overall costs. This briefing will educate about the established benefits of focused ultrasound, its potential in other areas of healthcare, and the value of additional research investment to advance this field of medicine.

Are you a current or aspiring inventor or entrepreneur? Would you like to learn from successful innovators and subject matter experts about keys to success? If so, register early for the February 24 Black Innovation and Entrepreneurship program hosted by the United States Patent and Trademark Office (USPTO).

Every third Friday of the month, G2G hosts this online event to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities, such as grants and BAAs that could accelerate company growth. We will share insights from our research and provide some Q&A during the first half hour. We then take a deeper dive on non-dilutive federal government funding sources and related priorities with consultation during the second half hour for our customers.

In the United States, the CDC estimates that 100,000 Americans have sickle cell disease (SCD). About 90% of people with SCD are of African descent. SCD also occurs in Hispanic, South Asian, Middle Eastern, and Southern European ancestry. A panel of experts, moderated by BioOhio’s Eddie Pauline, will discuss current programs that assist patients and families, as well as how Ohio’s hospital and health systems are contributing to SCD research and advancements in treatment.

For patients on Medicare, the majority of whom are over age 65, time matters. However, newly published research from the Stanford Byers Center for Biodesign shows that patients can wait up to 5 years after FDA authorization to access new medical technologies. Instead, a well-designed transitional coverage program could greatly accelerate patients’ access to care, while reducing the overall cost burden on our healthcare system. This program would also encourage innovation in areas of critically important unmet clinical needs. The Duke-Margolis Center for Health Policy has recommended the addition of several key elements to a transitional coverage pathway, highlighting the need for early engagement between stakeholders to inform and guide evidence development and appropriate use of novel technologies. Please join us to explore these findings and hear the perspectives of physicians, innovators and CMS stakeholders on this important initiative to advance patient care.

The Conference on Innovations in Climate Resilience, presented by Battelle in collaboration with DOE National Laboratories, offers a curated technical program with invited keynote presentations, platform and lightning talks and a poster reception. We’re expecting an audience of government leaders, entrepreneurs and innovators to explore breakthroughs in technology, science, policy and infrastructure that will help mitigate the threats to our environment, health, communities, national security and economic well-being from a changing climate.

Register today for MDMA’s flagship event, the 2022 MDMA Annual Meeting, which will be held, IN PERSON, April 27-29th. Hear from Congressional, Federal Agency and industry leaders and visit Capitol Hill during their popular Congressional Fly-In. *BioOhio Members can save $100! Contact a BioOhio team member for your discount code.

This annual conference brings together leading authorities from FDA, industry and academia to address the latest statistical trends and issues facing medtech organizations. In an effort to provide quality programming in the safest and most effective manner possible, the Conference will once again be held virtually this year. Dates: Wednesday, May 11th – Friday, May 13th

The labor crisis is happening now. Business leaders must take immediate actions to protect and expand their workforce in the short term. Part 1 of the Summit will share the current picture of Ohio’s workforce landscape, and present insights and approaches that every Ohio business can consider implementing today. We will explore organizational change management, incumbent upskilling, candidate recruitment expansion and other critically-immediate business actions that can strengthen business profitability and enhance quality of life for all. • Creating change for the long run. Building a workforce with the resilience to take on the unknown challenges of the future will require transformative, long-term action in the areas of education, economic development, and regional positioning. Together, these investments will drive long-term advantages in transportation, infrastructure, and community prosperity. Part 2 will present the long-term private sector solutions that every Ohio business can help power to reach that goal.

Mark your calendar for the BIO International Convention, June 13-16, 2022, in San Diego, held by BioOhio national partner, BIO! More information about the 2022 event will be made available in the coming months. Sign up for notifications about this event at BIO.org.